New Drug's heart risk under microscope in healthy volunteers
NCT ID NCT07272629
First seen Jan 10, 2026 · Last updated Apr 30, 2026 · Updated 16 times
Summary
This study checks whether a single dose of balinatunfib changes the heart's electrical activity in 44 healthy adults aged 18 to 55. Participants receive the drug, a placebo, and another heart-affecting drug in random order to compare effects. The goal is safety data, not treatment, so no direct benefit is expected for volunteers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
FORTREA CLINICAL RESEARCH UNIT INC- Site Number : 8400001
RECRUITINGMadison, Wisconsin, 53704, United States
-
FORTREA CLINICAL RESEARCH UNIT INC- Site Number : 8400002
RECRUITINGDallas, Texas, 75247, United States
Conditions
Explore the condition pages connected to this study.